TY  - JOUR
T1  - Patient- and physician-oriented web sites and drug surveillance: Bisphosphonates and severe bone, joint, and muscle pain
AU  - DeMonaco HJ
Y1  - 2009/06/22
N1  - 10.1001/archinternmed.2009.133
JO  - Archives of Internal Medicine
SP  - 1164
EP  - 1166
VL  - 169
IS  - 12
N2  - 
Postmarketing surveillance and the determination of the real-world safety profile of prescription drugs is arguably flawed. Recent identification of significant adverse effects associated with newly approved prescription drugs support the sometimes-held view that a new system needs to be introduced. The present voluntary system has not provided a sufficient early warning system, and some have called for active systems that probe for potential adverse effects of approved prescription drugs.1 Patient-oriented Web sites may provide an opportunity to identify potential adverse effects early in a drug's postmarket history.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2009.133
UR  - http://dx.doi.org/10.1001/archinternmed.2009.133
ER  -